Who
AH Bio Fund IV, L.P.
10% owner
Company insider
Files Form 4 as: 10% owner, Braveheart Bio.
In numbers
- Trades disclosed
- 3
- Buys
- 1
- Sells
- 0
- Bought
- $19.8M
- Sold
- $0
- Companies
- 1
- Companies where not an officer
- 1
- First trade
- 7 Aug 2026
- Last trade
- 7 Aug 2026
- Last filed
- 11 Aug 2026
Companies traded
Activity over time
1 Aug – 1 Oct
Buys above the line, sells below, each month.
Every trade
| Traded | Company | What | Amount | |
|---|---|---|---|---|
| 7 Aug 2026filed 11 Aug 2026 | BRVE Braveheart BioBiotechnology | SEC FORM 4 Code C | —9,132,420 | filing |
| 7 Aug 2026filed 11 Aug 2026 | BRVE Braveheart BioBiotechnology | SEC FORM 4 Bought | $19.8M1,100,000 at $18.00 | filing |
| 7 Aug 2026filed 11 Aug 2026 | BRVE Braveheart Biooption or derivative · Biotechnology | SEC FORM 4 Code C | —40,000,000 at $0.00 | filing |
News
Braveheart Bio (NASDAQ:BRVE) Stock Keeps "Overweight" Rating at Cantor FitzgeraldBRVE · themarketsdaily.com · 20 Oct 2026
0 headlines in the last 90 days name AH Bio Fund IV, L.P.; 1 article from the last 14 days about the 1 company they traded most, at most three about any one of them.